Insider filing
Traded Nov 5 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ASPE · NASDAQ · Pharmaceutical Preparations · No 10-K yet
Aspen Neuroscience (ASPE) · oqro.io/stocks/ASPE · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$12.59
Close of Nov 13, 2026 · end-of-day, not a live quote
Including 49 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Insider filing
Traded Nov 5 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
Traded Nov 2 · filed 2 days later
Since the trade −3.5% · S&P 500 +0.3% · to Nov 13
An Aspen Neuroscience director paid $15M out of pocket for Aspen Neuroscience shares. 3 other people at Aspen Neuroscience bought some too, in the same month. Shares held went up 39% with this purchase.
Insider buying
Traded Nov 2 · filed 2 days later
Since the trade −3.5% · S&P 500 +0.3% · to Nov 13
An Aspen Neuroscience director paid $15M out of pocket for Aspen Neuroscience shares. 3 other people at Aspen Neuroscience bought some too, in the same month. Shares held went up 39% with this purchase.
Traded Nov 2, 2026 · largest single transaction 626K
Nov 2, 2026626K
DetailsOfficial recordNov 2, 2026
Traded Nov 2, 2026 · largest single transaction 197K
Nov 2, 2026197K
DetailsOfficial recordNov 2, 2026643K
Traded Nov 2, 2026 · largest single transaction ~$18M
Nov 2, 2026~$18M · 1.2M sh @ $15.00
DetailsOfficial recordInsider buying
Traded Nov 2 · filed 1 day later
Since the trade −3.5% · S&P 500 +0.3% · to Nov 13
A major shareholder of Aspen Neuroscience paid $18M out of pocket for Aspen Neuroscience shares. 3 other people at Aspen Neuroscience bought some too, in the same month.
Traded Nov 2, 2026 · largest single transaction 180K
Nov 2, 2026180K
DetailsOfficial recordNov 2, 202670K
Insider filing
Traded Nov 2 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Nov 2, 2026 · largest single transaction 187K
Nov 2, 2026187K
DetailsOfficial recordNov 2, 2026298K
Nov 2, 2026197K
DetailsOfficial recordNov 2, 2026643K
DetailsOfficial recordNov 2, 2026197K
DetailsOfficial recordNov 2, 2026643K
DetailsOfficial recordNov 2, 2026617K
DetailsOfficial recordNov 2, 2026617K
DetailsOfficial recordNov 2, 2026626K
DetailsOfficial recordNov 2, 2026507K
DetailsOfficial recordNov 2, 2026617K
DetailsOfficial recordNov 2, 2026626K
DetailsOfficial recordNov 2, 2026507K
DetailsOfficial recordNov 2, 2026197K
DetailsOfficial recordNov 2, 2026643K
DetailsOfficial recordNov 2, 2026617K
DetailsOfficial recordNov 2, 2026626K
DetailsOfficial recordNov 2, 2026507K
DetailsOfficial recordNov 2, 2026~$1M · 67K sh @ $15.00
DetailsOfficial recordNov 2, 2026~$1M · 67K sh @ $15.00
DetailsOfficial recordNov 2, 2026180K
DetailsOfficial recordNov 2, 2026286K
DetailsOfficial recordNov 2, 2026295K
DetailsOfficial recordNov 2, 2026260K
DetailsOfficial recordNov 2, 2026298K
DetailsOfficial recordNov 2, 2026286K
DetailsOfficial recordNov 2, 2026295K
DetailsOfficial recordNov 2, 2026214K
DetailsOfficial recordNo earnings release (8-K Item 2.02) is on file for ASPE, so its insider trades cannot be placed against one.